These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8610226

  • 21. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [Abstract] [Full Text] [Related]

  • 26. Anticardiolipin antibodies: clinical consequences of "low titers".
    Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR, Branch DW.
    Obstet Gynecol; 1996 Apr; 87(4):494-500. PubMed ID: 8602297
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 29. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I, Levi Y, Godard G, Shoenfeld Y.
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [Abstract] [Full Text] [Related]

  • 30. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E.
    Lupus; 2007 Jun; 16(1):39-45. PubMed ID: 17283584
    [Abstract] [Full Text] [Related]

  • 31. Spontaneous coronary artery dissection in the context of positive anticardiolipin antibodies and clinically undiagnosed systemic lupus erythematosus.
    Nisar MK, Mya T.
    Lupus; 2011 Nov; 20(13):1436-8. PubMed ID: 21768175
    [Abstract] [Full Text] [Related]

  • 32. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome.
    Dalekos GN, Kistis KG, Boumba DS, Voulgari P, Zervou EK, Drosos AA, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):67-74. PubMed ID: 10656213
    [Abstract] [Full Text] [Related]

  • 33. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170
    [Abstract] [Full Text] [Related]

  • 34. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR.
    J Rheumatol; 1998 Nov 15; 25(11):2131-4. PubMed ID: 9818654
    [Abstract] [Full Text] [Related]

  • 35. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Nov 15; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 36. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
    Naarendorp M, Spiera H.
    J Rheumatol; 1998 Mar 15; 25(3):589-92. PubMed ID: 9517786
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 15; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 39. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
    Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN.
    Obstet Gynecol; 1997 Apr 15; 89(4):549-55. PubMed ID: 9083311
    [Abstract] [Full Text] [Related]

  • 40. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 15; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.